New Details on the Revision of USP Chapter 1
Recommendation

22/23 September 2026
Organisation of a GMP-compliant Site Change
As already reported in the news "Second Revision of USP Chapter <1> Injections and Implanted Drug Products (Parenterals)-Product Quality Tests", USP's Chapter <1> "Injections and Implanted Drug Products (Parenterals)-Product Quality Tests' has been revised again. New information is now available.
The USP published these details on 25 March. The revised version now contains a table of contents for a better overview whereas the Product Performance Test at the end of the Chapter has been deleted. All details about the new version of USP's Chapter <1> can be found on the USP website.
The revised Chapter will become effective on May 1st, 2016.
Related GMP News
22.07.2026Deviations in Aseptic Manufacturing: Warning Letter to a Japanese Pharmaceutical Manufacturer
15.07.2026The Relationship between Commissioning, Classification and Qualification in GMP Cleanrooms
01.07.2026Visual Inspection Group Developments [January through April 2026]
10.06.2026New Edition of ISO 14644-15 published
10.06.2026Revision of the DIN 11865 Standard for Stainless-Steel Components


